Olutasidenib
| Olutasidenib | |
|---|---|
| Term | Olutasidenib |
| Short definition | Ollier's disease - (pronounced) (oh-lee-AY dih-ZEEZ) rare condition that causes benign (noncancerous) growths of cartilage in the bones. These growths usually appear in the bones of the hands and feet, but can also appear in the skull, ribs, and spine. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Olutasidenib - (oh-LOO-tuh-SIH-deh-nib) drug used to treat adults with acute myeloid leukemia that has come back or has not improved with other treatments and has a mutation (change) in the IDH1 gene. It is also being studied in the treatment of other types of cancer. Olutasidenib blocks the protein made by the mutated IDH1 gene. Blocking this protein can help prevent cancer cells from growing. Olutasidenib is a type of enzyme inhibitor. Also called Rezlidhia
External links
- Medical encyclopedia article on Olutasidenib
- Wikipedia's article - Olutasidenib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski